Ownership history in CAXTON ASSOCIATES LP · 8 quarters on record
This page tracks every 13F SEC filing in which CAXTON ASSOCIATES LP reported a position in AVANOS MED INC (AVNS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | REDUCED | 8,612 | -8,423 | -49.4% | 0.01% | $207K | $24.03 |
| 2024 Q2 | ADDED | 17,035 | +2,034 | +13.6% | 0.01% | $339K | $19.92 |
| 2024 Q1 | REDUCED | 15,001 | -16,418 | -52.3% | 0.02% | $299K | $19.91 |
| 2023 Q4 | ADDED | 31,419 | +7,147 | +29.4% | 0.04% | $705K | $22.43 |
| 2023 Q3 | ADDED | 24,272 | +13,639 | +128.3% | 0.07% | $491K | $20.22 |
| 2023 Q1 | REDUCED | 10,633 | -2,475 | -18.9% | 0.05% | $316K | $29.74 |
| 2022 Q4 | ADDED | 13,108 | +2,048 | +18.5% | 0.02% | $355K | $27.06 |
| 2022 Q3 | INITIATED | 11,060 | — | — | 0.03% | $241K | $21.78 |
As of 2025 Q4 — sorted by position size